Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

732 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Hyperglycemia not hypoglycemia alters neuronal dendrites and impairs spatial memory.
Malone JI, Hanna S, Saporta S, Mervis RF, Park CR, Chong L, Diamond DM. Malone JI, et al. Among authors: hanna s. Pediatr Diabetes. 2008 Dec;9(6):531-9. doi: 10.1111/j.1399-5448.2008.00431.x. Pediatr Diabetes. 2008. PMID: 19067891
Hyperglycemic brain injury in the rat.
Malone JI, Hanna SK, Saporta S. Malone JI, et al. Among authors: hanna sk. Brain Res. 2006 Mar 3;1076(1):9-15. doi: 10.1016/j.brainres.2005.12.072. Epub 2006 Feb 17. Brain Res. 2006. PMID: 16487498
Diabetes-induced bradycardia is an intrinsic metabolic defect reversed by carnitine.
Malone MA, Schocken DD, Hanna SK, Liang X, Malone JI. Malone MA, et al. Metabolism. 2007 Aug;56(8):1118-23. doi: 10.1016/j.metabol.2007.04.005. Metabolism. 2007. PMID: 17618959
Correlates of adiponectin and the leptin/adiponectin ratio in obese and non-obese children.
Diamond FB Jr, Cuthbertson D, Hanna S, Eichler D. Diamond FB Jr, et al. Among authors: hanna s. J Pediatr Endocrinol Metab. 2004 Aug;17(8):1069-75. doi: 10.1515/jpem.2004.17.8.1069. J Pediatr Endocrinol Metab. 2004. PMID: 15379417 Clinical Trial.
The importance of tumor glucuronidase in the activation of irinotecan in a mouse xenograft model.
Dodds HM, Tobin PJ, Stewart CF, Cheshire P, Hanna S, Houghton P, Rivory LP. Dodds HM, et al. Among authors: hanna s. J Pharmacol Exp Ther. 2002 Nov;303(2):649-55. doi: 10.1124/jpet.102.039040. J Pharmacol Exp Ther. 2002. PMID: 12388647
Effect of radiation on the penetration of irinotecan in rat cerebrospinal fluid.
Khatri A, Gaber MW, Brundage RC, Naimark MD, Hanna SK, Stewart CF, Kirstein MN. Khatri A, et al. Cancer Chemother Pharmacol. 2011 Sep;68(3):721-31. doi: 10.1007/s00280-010-1542-3. Epub 2010 Dec 16. Cancer Chemother Pharmacol. 2011. PMID: 21161529
Pharmacokinetics of irinotecan and its metabolites SN-38 and APC in children with recurrent solid tumors after protracted low-dose irinotecan.
Ma MK, Zamboni WC, Radomski KM, Furman WL, Santana VM, Houghton PJ, Hanna SK, Smith AK, Stewart CF. Ma MK, et al. Among authors: hanna sk. Clin Cancer Res. 2000 Mar;6(3):813-9. Clin Cancer Res. 2000. PMID: 10741701 Clinical Trial.
Relationship between tumor extracellular fluid exposure to topotecan and tumor response in human neuroblastoma xenograft and cell lines.
Zamboni WC, Houghton PJ, Hulstein JL, Kirstein M, Walsh J, Cheshire PJ, Hanna SK, Danks MK, Stewart CF. Zamboni WC, et al. Among authors: hanna sk. Cancer Chemother Pharmacol. 1999;43(4):269-76. doi: 10.1007/s002800050894. Cancer Chemother Pharmacol. 1999. PMID: 10071976
Studies of the efficacy and pharmacology of irinotecan against human colon tumor xenograft models.
Zamboni WC, Stewart CF, Cheshire PJ, Richmond LB, Hanna SK, Luo X, Poquette C, McGovren JP, Houghton JA, Houghton PJ. Zamboni WC, et al. Among authors: hanna sk. Clin Cancer Res. 1998 Mar;4(3):743-53. Clin Cancer Res. 1998. PMID: 9533544
Altered irinotecan and SN-38 disposition after intravenous and oral administration of irinotecan in mice bearing human neuroblastoma xenografts.
Zamboni WC, Houghton PJ, Thompson J, Cheshire PJ, Hanna SK, Richmond LB, Lou X, Stewart CF. Zamboni WC, et al. Among authors: hanna sk. Clin Cancer Res. 1998 Feb;4(2):455-62. Clin Cancer Res. 1998. PMID: 9516936
732 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback